De Bari Berardino, MD, Radiation Oncologist (@debariberardino) 's Twitter Profile
De Bari Berardino, MD, Radiation Oncologist

@debariberardino

Head of the Radiation Oncology Dpt - La Chaux-de-Fonds (Switzerland), ESTRO and ESO teacher but also....
Songwriter...follow me @FreefoxSongwri1

ID: 1670698110006464513

linkhttps://www.rhne.ch/radio-oncologie calendar_today19-06-2023 07:40:55

8 Tweet

62 Takipçi

80 Takip Edilen

Icro Meattini (@icro_meattini) 's Twitter Profile Photo
Icro Meattini
@icro_meattini

3 years ago

Lovely to conclude the first day #FlorenceBreast23 with a simultaneous publication of our first project-related paper! Safety profile of CDK4/6 inhibitors with concurrent #radiotherapy - systematic review and meta-analysis sciencedirect.com/science/articl… OncoAlert ESTRO #OncoAlert

Icro Meattini (@icro_meattini) 's Twitter Profile Photo
Icro Meattini
@icro_meattini

3 years ago

Safety profile of CDK4/6 inhibitors with concurrent #radiotherapy : a systematic review and meta-analysis #FlorenceBreast23 #OncoAlert OncoAlert 50 days' free access link to our paper authors.elsevier.com/a/1hGP315X3%7E…

Gustavo (@gusviani) 's Twitter Profile Photo
Gustavo
@gusviani

3 years ago

🎙️Re-irradiation shows promise in IDH-wt GBM ‼️ 📌Retrospective analysis of IDH-wt GBM ➡️ re-RT 🏥 Single-center, 88 👥 📊results: 👉Median OS: 8.0 mo 👉Gross total resection 🔛 OS 👉Median PFS: 5.9 mo 👉NO sig factors 🔛PFS ⚠️ NO evidence of RN recorded #GBM #Reirradiation

🎙️Re-irradiation shows promise in IDH-wt GBM ‼️ 📌Retrospective analysis of IDH-wt GBM ➡️ re-RT 🏥 Single-center, 88 👥 📊results: 👉Median OS: 8.0 mo 👉Gross total resection 🔛 OS 👉Median PFS: 5.9 mo 👉NO sig factors 🔛PFS ⚠️ NO evidence of RN recorded #GBM #Reirradiation
Jame Abraham, MD, FACP (@jamecancerdoc) 's Twitter Profile Photo
Jame Abraham, MD, FACP
@jamecancerdoc

3 years ago

Artificial Intelligence and Machine Learning in Clinical Medicine, 2023 | NEJM OncoAlert nejm.org/doi/full/10.10…

Artificial Intelligence and Machine Learning in Clinical Medicine, 2023 | <a href="/NEJM/">NEJM</a> <a href="/OncoAlert/">OncoAlert</a> nejm.org/doi/full/10.10…
Gustavo (@gusviani) 's Twitter Profile Photo
Gustavo
@gusviani

3 years ago

🎙️Nice review on Cutaneous Squamous-Cell Carcinoma including RT: NEJM 👉🥇Tumor: ⚕️ Consider RT for non-🔪candidates 👉Adjuvant Therapy: 🔎 Debated, but NCCN & ACR recommend it for ➕margins & high-risk features 📊 Retro studies➡️⤴️OS & DFS ⤵️ recurrence rates w/o adjuvant RT

🎙️Nice review on Cutaneous Squamous-Cell Carcinoma including RT: <a href="/NEJM/">NEJM</a> 👉🥇Tumor: ⚕️ Consider RT for non-🔪candidates 👉Adjuvant Therapy: 🔎 Debated, but NCCN &amp; ACR recommend it for ➕margins &amp; high-risk features 📊 Retro studies➡️⤴️OS &amp; DFS ⤵️ recurrence rates w/o adjuvant RT
Filippo Alongi (@alongi_filippo) 's Twitter Profile Photo
Filippo Alongi
@alongi_filippo

3 years ago

150 bone Mts in 95 pts received 30-35 Gy in 5Fx.With a median FUP of 26 months, 1- and 3 y LPFS was 96.3% and 89%, respectively. BED≥ 198 Gy was correlated with🔼 LPFS. Oligorecurrent was associated with better PMFS compared to de novo. No grade ≥ 3 tox .#radonc

150 bone Mts in 95 pts received 30-35 Gy in 5Fx.With a median FUP of 26 months, 1- and 3 y LPFS was 96.3% and 89%, respectively. BED≥ 198 Gy was correlated with🔼 LPFS. Oligorecurrent was associated with better PMFS compared to de novo. No grade ≥ 3 tox .#radonc
De Bari Berardino, MD, Radiation Oncologist (@debariberardino) 's Twitter Profile Photo
De Bari Berardino, MD, Radiation Oncologist
@debariberardino

3 years ago

Another negative trial in GBL... The person who will improve OS in GBL patients really deserves Nobel prize!!

Jeff Michalski (@jmmrad) 's Twitter Profile Photo
Jeff Michalski
@jmmrad

3 years ago

It is with profound sadness that I share the news of today's passing of Dr. Carlos A Perez, former Chair of Radiation Oncology at Washington University and the Mallinckrodt Institute of Radiology. @WashURadOnc ASTRO beckerexhibits.wustl.edu/mig/bios/perez…

It is with profound sadness that I share the news of today's passing of Dr. Carlos A Perez, former Chair of Radiation Oncology at Washington University and the Mallinckrodt Institute of Radiology. @WashURadOnc <a href="/ASTRO_org/">ASTRO</a> beckerexhibits.wustl.edu/mig/bios/perez…